abeglutide glp-1 Agonists: A Comprehensive Overview GLP-1-based therapies for diabetes, obesity

These results showed that GSH-conjugation catalyzed by GSTs may reduce the impact of trichothecenes (Gardiner et al., 2010)

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study

Histological analysis showed that FOXO4-DRI treatment improved the testicular microenvironment, leading to thicker seminiferous epithelia, increased spermatogenic cells, and more mature spermatozoa in the central lumen

This will be the first time that Medicare will be able to cover Food & Drug Administration (FDA)-approved for beneficiaries

Those with type 2 diabetes lost 17% of their body weight and saw improvements in blood sugar